Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Sep 1;67(0 1):S87–S95. doi: 10.1097/QAI.0000000000000254

Table 1.

Research agenda on the cost-effectiveness and implementation of integration of non-communicable disease (NCD) management with HIV care for people in low- and middle-income countries (LMICs).

1) To assess the cost-effectiveness of NCD management for PLHIV in LMICs, collect data on:
  • Epidemiology: to determine prevalence, incidence, and attributable mortality by demographics and region

  • Quality of Life: to examine the impact of co-morbid NCD diagnoses and their treatments

  • Screening: to evaluate the test characteristics, yield, and outcomes

  • Treatment: to assess the availability and outcomes of NCD management strategies

  • Costs: to quantify the resource use of screening, treatment, and management of NCD clinical outcomes

2) To investigate optimal strategies for integration of expanded screening and treatment of NCDs in PLHIV, collect data on:
  • Outcomes: to measure clinical and economic outcomes with both distinct as well as integrated care

  • Time points: to determine short-term and long-term outcomes, including linkage to and retention in care

3) To utilize existing clinical and research platforms, extend research training in LMICs in the following fields:
  • Clinical epidemiology

  • Implementation science

  • Cost-effectiveness analysis

  • Mathematical modeling